CHAC1 and ovarian carcinoma: Overexpression of human CHAC1 also led to a robust depletion of glutathione in HEK293 cells.5 Moreover, Goebel et al.6 reported that elevated mRNA expression of CHAC1 splicing variants is associated with poor outcome for breast and ovarian cancer patients.